These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 26101165)

  • 1. Being human: The role of pluripotent stem cells in regenerative medicine and humanizing Alzheimer's disease models.
    Sproul AA
    Mol Aspects Med; 2015; 43-44():54-65. PubMed ID: 26101165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiation of pluripotent stem cells for regenerative medicine.
    Li K; Kong Y; Zhang M; Xie F; Liu P; Xu S
    Biochem Biophys Res Commun; 2016 Feb; 471(1):1-4. PubMed ID: 26851367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein-Induced Pluripotent Stem Cells Ameliorate Cognitive Dysfunction and Reduce Aβ Deposition in a Mouse Model of Alzheimer's Disease.
    Cha MY; Kwon YW; Ahn HS; Jeong H; Lee YY; Moon M; Baik SH; Kim DK; Song H; Yi EC; Hwang D; Kim HS; Mook-Jung I
    Stem Cells Transl Med; 2017 Jan; 6(1):293-305. PubMed ID: 28170178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of human organs in pigs via interspecies blastocyst complementation.
    Wu J; Platero Luengo A; Gil MA; Suzuki K; Cuello C; Morales Valencia M; Parrilla I; Martinez CA; Nohalez A; Roca J; Martinez EA; Izpisua Belmonte JC
    Reprod Domest Anim; 2016 Oct; 51 Suppl 2():18-24. PubMed ID: 27762052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling Alzheimer's disease with human induced pluripotent stem (iPS) cells.
    Mungenast AE; Siegert S; Tsai LH
    Mol Cell Neurosci; 2016 Jun; 73():13-31. PubMed ID: 26657644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alzheimer's disease modeling: ups, downs, and perspectives for human induced pluripotent stem cells.
    Wojda U; Kuznicki J
    J Alzheimers Dis; 2013; 34(3):563-88. PubMed ID: 23313930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent approaches and challenges in iPSCs: modeling and cell-based therapy of Alzheimer's disease.
    Csöbönyeiová M; Polák Š; Danišovič L
    Rev Neurosci; 2016 Jul; 27(5):457-64. PubMed ID: 26812864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current applications of human pluripotent stem cells: possibilities and challenges.
    Ho PJ; Yen ML; Yet SF; Yen BL
    Cell Transplant; 2012; 21(5):801-14. PubMed ID: 22449556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of human induced pluripotent stem cells for modeling and treating neurodegenerative diseases.
    Payne NL; Sylvain A; O'Brien C; Herszfeld D; Sun G; Bernard CC
    N Biotechnol; 2015 Jan; 32(1):212-28. PubMed ID: 24815224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopaminergic differentiation using pluripotent stem cells.
    Momčilović O; Montoya-Sack J; Zeng X
    J Cell Biochem; 2012 Dec; 113(12):3610-9. PubMed ID: 22807388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induced pluripotent stem cells in Alzheimer's disease: applications for disease modeling and cell-replacement therapy.
    Yang J; Li S; He XB; Cheng C; Le W
    Mol Neurodegener; 2016 May; 11(1):39. PubMed ID: 27184028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neural stem cells in regenerative medicine: bridging the gap.
    Ruff CA; Fehlings MG
    Panminerva Med; 2010 Jun; 52(2):125-47. PubMed ID: 20517196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploiting pluripotency for therapeutic gain.
    Deng W
    Panminerva Med; 2010 Jun; 52(2):167-73. PubMed ID: 20517198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human Pluripotent Stem Cells as In Vitro Models of Neurodegenerative Diseases.
    Machairaki V
    Adv Exp Med Biol; 2020; 1195():93-94. PubMed ID: 32468463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pluripotent stem cells: the last 10 years.
    Kimbrel EA; Lanza R
    Regen Med; 2016 Dec; 11(8):831-847. PubMed ID: 27908220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling familial Alzheimer's disease with induced pluripotent stem cells.
    Yagi T; Ito D; Okada Y; Akamatsu W; Nihei Y; Yoshizaki T; Yamanaka S; Okano H; Suzuki N
    Hum Mol Genet; 2011 Dec; 20(23):4530-9. PubMed ID: 21900357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. iPSCs, aging and age-related diseases.
    Isobe K; Cheng Z; Nishio N; Suganya T; Tanaka Y; Ito S
    N Biotechnol; 2014 Sep; 31(5):411-21. PubMed ID: 24784583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential use of iPSCs for disease modeling, drug screening, and cell-based therapy for Alzheimer's disease.
    Marei HE; Khan MUA; Hasan A
    Cell Mol Biol Lett; 2023 Nov; 28(1):98. PubMed ID: 38031028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concise Review: Modeling Neurodegenerative Diseases with Human Pluripotent Stem Cell-Derived Microglia.
    Haenseler W; Rajendran L
    Stem Cells; 2019 Jun; 37(6):724-730. PubMed ID: 30801863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stem-cell challenges in the treatment of Alzheimer's disease: a long way from bench to bedside.
    Fan X; Sun D; Tang X; Cai Y; Yin ZQ; Xu H
    Med Res Rev; 2014 Sep; 34(5):957-78. PubMed ID: 24500883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.